BiliaryTractCancer near Brooklyn, NY

Biography: Dr. Uqba Khan is an Assistant Professor of Clinical Medicine within the faculty of Weill Cornell Medical College in the Division of Hematology and Medical Oncology. Dr. Khan is also an Attending Physician at NewYork-Presbyterian Brooklyn Methodist Hospital.Dr. Khan received his medical degree from Allama Iqbal Medical College, Pakistan in 2008. He underwent his internal medicine training at St. Agnes Hospital in Baltimore and later completed his hematology/oncology fellowship at St. John Hospital and Medical Center in Detroit, where he also served as chief fellow. Dr. Khan has a special interest in treatment of gastrointestinal (GI) malignancies and clinical research. He joined Weill Cornell Medicine in 2018 to complete an additional year of training in management of gastrointestinal malignancies. He also worked as an instructor at Weill Cornell Medical College between 2018 and 2019. In June of 2019, Dr. Khan was promoted to Assistant Professor of Clinical Medicine within the faculty of Weill Cornell Medical College in the Division of Hematology and Medical Oncology.Dr. Khan has been involved in a number of clinical and translational research studies. His research focuses on optimizing the effectiveness of immunotherapy in solid malignancies. He has published a number of research articles and is actively involved as an investigator in several clinical trials. He has presented his research findingsat several professional conferences and meetings.Dr. Khan is a member of several national and international professional societies, including the American Society of Clinical Oncology (ASCO), the Society of Immunotherapy in Cancer (SITC), the European Society of Medical Oncology (ESMO) and the American Association for Cancer Research (AACR).

Care Philosophy: "I am a medical oncologist with an expertise in breast cancer medicine. My focus is the multidisciplinary care and treatment of patients, especially those who have tumors that are high risk. Because I am a passionate advocate of personalized medicine, my goal is to develop new successful treatments that exploit our knowledge of the cancer genome and the immuno cell network for immunotherapy, in order to improve the outcomes of breast cancer patients. To do this, I actively participate in team science and recognize the importance of establishing strong connections with other disciplines involved in the care of patients and who are in the laboratory, as our goals are the same- to cure breast cancer. I view my patients as individuals and welcome open and inclusive communication when discussing treatment strategies as it is paramount they feel comfortable with an established treatment pathway."